TY  - CHAP
M1  - Book, Section
TI  - Chapter 240. Cystic Fibrosis
A1  - Tong, David
A1  - Stecenko, Arlene
A2  - McKean, Sylvia C.
A2  - Ross, John J.
A2  - Dressler, Daniel D.
A2  - Brotman, Daniel J.
A2  - Ginsberg, Jeffrey S.
Y1  - 2012
N1  - 
T2  - Principles and Practice of Hospital Medicine
AB  - How  do  mutations  in  the  cystic  fibrosis  (CF)  gene  relate  to  the  clinical  manifestations  of  the  disease?What  criteria  help  determine  when  a  CF  patient  should  be  admitted  to  hospital  for  respiratory  complications  of  the  disease?What  treatment  modalities  are  most  effective  in  restoring  lung  function  to  baseline  for  CF  respiratory  exacerbations?Why  is  CF–related  diabetes  (CFRD)  one  of  the  most  important  comorbidities  in  CF  and  how  does  it  alter  the  course  of  the  disease?What  are  the  most  effective  treatment  modalities  for  the  two  most  common  pulmonary  complications  of  CF:  massive  hemoptysis  and  pneumothorax?  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2023/09/23
UR  - accessmedicine.mhmedical.com/content.aspx?aid=56214566
ER  -